Lausanne hospital test chosen for coronavirus study
A Covid-19 antibody test developed at Lausanne university hospital (CHUV) has been chosen for wide-scale studies of the Swiss population, the hospital has announced.
This content was published on
1 minute
Keystone-SDA/jc
Selection of a single serology test was necessary for consistent and comparable data at national level, CHUV said on Thursday.
The hospital announced in June that one of its teams had developed a new coronavirus antibody blood test in collaboration with the Federal Institute of Technology Lausanne (EPFL) and the Swiss Vaccine Research Institute.
“Compared to other commercially available tests, the technology developed at the CHUV has a 15-30% higher sensitivity, making it possible to detect antibodies to SARS-CoV-2 long after infection, even in people with few or no symptoms,” CHUV said in a press release.
Corona Immunitas, the government-backed antibody testing programme, has now chosen it for nationwide tests. Supported by the Federal Office of Public Health (FOPH), Corona Immunitas is in charge of coordinating more than 20 population studies to estimate the number of people infected with SARS-CoV-2 in Switzerland.
Such studies are very useful from an epidemiological point of view and may also help determine immunity levels to the virus.
Popular Stories
More
Foreign affairs
What Trump’s return or a new Harris administration would mean for Switzerland
More than 400,000 cross-border commuters now work in Switzerland
This content was published on
More than half of all cross-border commuters were resident in France (around 57%). Large proportions also lived in Italy (23%) and Germany (around 16%).
Amherd and von der Leyen discuss ongoing Swiss-EU negotiations
This content was published on
Swiss President Viola Amherd and EU Commission President Ursula von der Leyen have met and talked about the ongoing negotiations between Bern and Brussels.
This content was published on
One million francs, 34 million euros and around 830 kilos of gold: this is the fortune that two Swiss nationals are accused of having moved across borders for at least four years.
Girls in female-dominated classes earn more later on
This content was published on
At the age of 30, women from school classes with a 55% share of girls earn $350 more per year than women from classes with a 45% share of girls.
This content was published on
Geneva-based luxury goods group Richemont reported a downturn in performance for the first half of its 2024/25 financial year. Both sales and profit declined.
COP29: Swiss NGOs call for strong financial support
This content was published on
Ahead of COP29, Swiss NGOs call for wealthy nations to pay $1,000 billion a year to help other countries solve climate problems.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland mulls controversial Covid-19 health passports
This content was published on
Swiss technology firms and medical researchers are developing digital health passports that could be used to certify who is immune to Covid-19.
Roche in talks with Britain on Covid-19 antibody test
This content was published on
Britain is in talks with Swiss drugmaker Roche on rolling out an accurate Covid-19 antibody test that it said could be a game changer.
This test could help Switzerland get back on track
This content was published on
While we await a vaccine or treatment, scientists are developing tests to tell us how widespread the virus is, such as the serological test.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.